{"id":"W3031324523","doi":"10.1016/s2665-9913(20)30066-7","title":"5-year efficacy and safety of secukinumab in patients with ankylosing spondylitis: end-of-study results from the phase 3 MEASURE 2 trial","year":2020,"lang":"en","type":"article","venue":"The Lancet Rheumatology","topic":"Spondyloarthritis Studies and Treatments","field":"Medicine","cited_by":24,"is_retracted":false,"has_abstract":false,"ca_institutions":"McGill University","funders":"Novartis Pharmaceuticals UK Limited; National Institute for Health and Care Research; NIHR Biomedical Research Centre, Royal Marsden NHS Foundation Trust/Institute of Cancer Research","keywords":"Secukinumab; Ankylosing spondylitis; Medicine; Measure (data warehouse); Clinical trial; Phase (matter); Internal medicine; Rheumatoid arthritis; Computer science; Data mining; Physics","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002537472,0.0001405858,0.000807634,0.00002195401,0.00007102379,0.000004689667,0.0001181469,0.00004815045,0.00004061709],"category_scores_gemma":[0.0004486178,0.00007276017,0.00003501848,0.0001736978,0.0002149808,0.00002384704,0.00007575034,0.0001787627,0.000002049184],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00001565273,"about_ca_system_score_gemma":0.00004356388,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0006522848,"about_ca_topic_score_gemma":0.0002391957,"domain_scores_codex":[0.9986532,0.0002285444,0.0004494244,0.0002455798,0.0002212179,0.000202084],"domain_scores_gemma":[0.998812,0.0005357036,0.000209461,0.0003368517,0.00006316921,0.0000428261],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.4431817,0.001126523,0.5406045,0.00002288212,0.0004367915,0.0000337682,0.01069899,0.000001154291,0.000008029439,0.0001374363,0.0001972243,0.003551045],"study_design_scores_gemma":[0.5173117,0.005229018,0.4745461,0.0002919071,0.0001738938,0.000009586098,0.001569254,0.000008092115,0.00004014005,0.00002714793,0.0007111386,0.00008204958],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9948494,0.0006070921,0.000002221396,0.002128774,0.00007839232,0.001296569,0.0008061744,0.00001487532,0.0002165129],"genre_scores_gemma":[0.9995062,0.0001272981,0.00006716318,0.0001009569,0.00004213344,0.00001510072,0.0001274526,0.00001223698,0.000001434918],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.07412998,"threshold_uncertainty_score":0.2967074,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.03062192535098186,"score_gpt":0.2818879644821985,"score_spread":0.2512660391312166,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}